Abivax S.A.
ABVX
73.20
-7.45
-9.24%
Abivax S.A.
US · ABVX
#1658 by market cap
Listed 2023
73.20
-7.45
-9.24%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions increased by 18 in the most recent period (2026/Q3).
- Total institutional ownership fell 3.2 percentage points.
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 114.78% -3.21pp
- Institutions
- 416 +18
- As of
- 2026/Q3 vs. prior period
Holder types
Hedge Fund34.59%
VC/PE Fund29.74%
Mutual Fund25.85%
Public Company15.39%
Private Company4.79%
Sovereign Wealth Fund3.68%
Individual/Insider1.13%
Endowment Fund0.48%
Insurance Company0.12%
Top holders as of 2026-06-30
TCG Crossover Management, LLC
6.89% · 6.01M sh
The Goldman Sachs Group, Inc.
5.42% · 4.73M sh
Artal Group S.A.
5.09% · 4.44M sh
Helikon Investments Limited
5.02% · 4.38M sh
Darwin Global Management Limited
4.99% · 4.35M sh
JPMorgan Chase & Co.
4.48% · 3.91M sh
VR Management, LLC
4.14% · 3.61M sh
Bank of America Corporation
3.64% · 3.17M sh
Norges Bank Investment Management
3.68% · 3.20M sh
Deep Track Capital, LP
3.64% · 3.17M sh
Vanguard Capital Management, LLC
3.44% · 3.00M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
2 filings tracked · 0 buys · 2 sells
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-01-07 | Sofinnova Partners SAS | -- | Intent to Sell (Form 144) | -1,000,000 | $133.70 |
| 2025-10-27 | Sofinnova Partners SAS | -- | Intent to Sell (Form 144) | -1,200,000 | $92.75 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.
Abivax S.A. discussion 0 comments